Glycerin Laxative
- Product NDC
- 13709-322
- 11-digit product format
- 137090322
- Labeler code
- 13709
- Product ID
- 13709-322_2beb2049-b67f-b7a5-e063-6394a90a3a15
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Glycerin based Gentle and Effective Laxative Adult Constipation Relief
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- NeilMed Pharmaceuticals Inc.
- Application
- M015
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-08-24
- Substance
- GLYCERIN
- Active strength
- 2 g/1
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 13709-322 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… | ||
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 13709-322 | 13709-322-01 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glycerin Laxative
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLYCERIN | 2 g/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| PDC6A3C0OX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 104155 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 03b4be69-6488-76be-e063-6394a90a7edf | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3c386306-c48a-413e-bb69-70cb268496f3 | Product name | 1 | 20210727 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13709-322-01 | Glycerin Laxative | 25 in 1 JAR | SUPPOSITORY | 25 | 2 | |
| 13709-322-01 | Glycerin Laxative | 1 in 1 CAPSULE | SUPPOSITORY | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 13709-322 | GLYCERIN LAXATIVE (GLYCERIN BASED GENTLE AND EFFECTIVE LAXATIVE ADULT CONSTIPATION RELIEF) SUPPOSITORY [NEILMED PHARMACEUTICALS INC.] | 2 | Current NDC, 2 package rows | 20250119_03b4be69-6488-76be-e063-6394a90a7edf.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | 4eb3c9ac-268a-5246-e054-00144ff88e88 | 2025-06-09 | Warnings | M015 |
| Bunnies Bum Anorectal Numbing | LIDOCAINE | FloCal Distributors LLC | 3712e151-d171-1c5d-e063-6294a90a36c0 | 2025-06-08 | Warnings | M015 |
| RECOVERY Numbing | LIDOCAINE HCL | Renu Laboratories, LLC | e4e05cae-56a6-b2b3-e053-2a95a90a104b | 2025-06-06 | Warnings | M015 |
| Hemorrohoid Master Cream | LIDOCAINE, PHENYLEPHRINE HCL | Ebanel Laboratories, Inc. | 36eccc74-107e-3914-e063-6294a90a1856 | 2025-06-06 | Warnings | M015 |
| Numb 520 | LIDOCAINE | Ebanel Laboratories, Inc | 36c9988b-9e61-ebbf-e063-6394a90a4114 | 2025-06-04 | Warnings | M015 |
| Hemorrhoid Master | LIDOCAINE, PHENYLEPHRINE HCL | Clinical Resolution Laboratory, Inc. | 36caf20d-116a-f86a-e063-6294a90a7b62 | 2025-06-04 | Warnings | M015 |
| Quick Numb | LIDOCAINE | Clinical Resolution Laboratory, Inc. | 351b95a6-e038-d9aa-e063-6294a90a4172 | 2025-05-29 | Warnings | M015 |
| Dibucaine Topical Anesthetic 1% Hemorrhoidal | DIBUCAINE | Rugby Laboratories Inc. | f23c8cd1-98f9-41cd-84d4-cf01c2ede29a | 2025-05-29 | Warnings | M015 |
| The Femme Fix Hemorrhoid Treatment | LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE | POPPY COLLECTIVE LLC | 5217b5d9-b835-4428-a6b3-e6b255630742 | 2025-05-27 | Warnings | M015 |
| MAXOCAINE Topical Anesthetic Anorectal | LIDOCAINE | PRIME COMMERCE, LLC | 26e8c867-8cb8-4a25-91b1-da45a1edd09a | 2025-05-27 | Warnings | M015 |
| Numb25 | LIDOCAINE | Ebanel Laboratories, Inc. | 35107403-55ae-c627-e063-6394a90a0b5c | 2025-05-27 | Warnings | M015 |
| Numb 520 | LIDOCAINE | Ebanel Laboratories, Inc | 350e4d5e-dac7-ae4e-e063-6394a90a76b4 | 2025-05-27 | Warnings | M015 |
| Numb25 | LIDOCAINE 5% | Ebanel Laboratories, Inc | 350fd302-8fd5-5288-e063-6294a90aa382 | 2025-05-27 | Warnings | M015 |
| Numb 520 | LIDOCAINE | Ebanel Laboratories, Inc | 35095bed-0e91-c44a-e063-6294a90add6e | 2025-05-27 | Warnings | M015 |
| Numb520 | LIDOCAINE | Clinical Resolution Laboratory, Inc. | a0411950-c6ee-4427-acb6-3cef58b0e93e | 2025-05-15 | Warnings | M015 |
| Numb25 | LIDOCAINE | Clinical Resolution Laboratory, Inc. | cfcb839d-47b4-4925-bb30-97b64d20d2b3 | 2025-05-15 | Warnings | M015 |
| Numb520 | LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE | Clinical Resolution Laboratory, Inc. | 65d3b614-361d-4fb9-9583-a95be754bc82 | 2025-05-15 | Warnings | M015 |
| Chamosyn | BARRIER CREAM | Links Medical Products | f9dfb2d7-4684-4525-994e-1e0ff90413d9 | 2025-05-08 | Warnings | M015 |
| LANOZEM HEMORRHOIDAL | MENTHOL, PETROLATUM | Sod-e Biotech Ltd | 34901e83-8f24-8460-e063-6394a90a2744 | 2025-05-07 | Warnings | M015 |
| PREPARATION H | PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | 96d2e0e7-2de0-4660-9ffd-9edb2ad224d8 | 2025-04-18 | Warnings | M015 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 104155 | glycerin 2 GM Rectal Suppository | PSN | 03b4be69-6488-76be-e063-6394a90a7edf | 2 |
| 104155 | glycerin 2000 MG Rectal Suppository | SCD | 03b4be69-6488-76be-e063-6394a90a7edf | 2 |
| 104155 | glycerin 2 GM Rectal Suppository | SY | 03b4be69-6488-76be-e063-6394a90a7edf | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 13709-322-01 | 13709032201 | 25 CAPSULE in 1 JAR (13709-322-01) / 1 SUPPOSITORY in 1 CAPSULE | 25 capsule | 2023-08-24 | No | No | Current |